Andrew G Glass

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. doi request reprint Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting
    Andrew G Glass
    Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon Electronic address
    J Urol 195:1748-53. 2016
  2. ncbi request reprint Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
    Andrew G Glass
    Oncology Research, Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227, USA
    J Natl Cancer Inst 99:1152-61. 2007
  3. ncbi request reprint Prostate cancer screening and mortality: a case-control study (United States)
    Sheila Weinmann
    Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Avenue, Portland, OR 97227, USA
    Cancer Causes Control 15:133-8. 2004
  4. pmc Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852 7234, USA
    Cancer 113:2073-81. 2008
  5. pmc PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA
    Cancer Res 68:6014-20. 2008
  6. doi request reprint Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells
    Silke Kaulfuss
    Institute of Human Genetics, University of Gottingen, Heinrich Düker Weg 12, Gottingen, Germany
    Mol Endocrinol 22:1606-21. 2008
  7. ncbi request reprint Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer
    Yan Cui
    Office of Health Assessment and Epidemiology, Los Angeles County Department of Public Health, Los Angeles, California, USA
    Cancer Epidemiol Biomarkers Prev 16:1682-5. 2007
  8. ncbi request reprint Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?
    Derek Weycker
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 40:402-7. 2006
  9. ncbi request reprint Response to "Use of cervical cancer screening among insured women: the extent of missed opportunities" [Health Policy 73 (2005) 194-201]
    Ralph P Insinga
    Health Policy 77:245-6. 2006
  10. ncbi request reprint The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
    Michelle J Khan
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 7074, Rockville, MD 20852, USA
    J Natl Cancer Inst 97:1072-9. 2005

Collaborators

Detail Information

Publications16

  1. doi request reprint Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting
    Andrew G Glass
    Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon Electronic address
    J Urol 195:1748-53. 2016
    ..We determined the value of Decipher®, a genomic classifier, to predict prostate cancer outcomes among patients after prostatectomy in a community health care setting...
  2. ncbi request reprint Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
    Andrew G Glass
    Oncology Research, Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227, USA
    J Natl Cancer Inst 99:1152-61. 2007
    ..We examined the potential association between menopausal hormone therapy use and recent changes in breast cancer incidence...
  3. ncbi request reprint Prostate cancer screening and mortality: a case-control study (United States)
    Sheila Weinmann
    Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Avenue, Portland, OR 97227, USA
    Cancer Causes Control 15:133-8. 2004
    ..We performed a case-control study at Kaiser Permanente Northwest to assess the association between digital rectal examination (DRE) and prostate-specific antigen (PSA) testing, separately and together, and prostate cancer mortality...
  4. pmc Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852 7234, USA
    Cancer 113:2073-81. 2008
    ..The authors estimated progression risk associated with EIN among endometrial biopsies in a nested case-control study of EH progression...
  5. pmc PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA
    Cancer Res 68:6014-20. 2008
    ..Loss of PTEN expression in endometrial biopsies was neither associated with nor a sensitive and specific marker of subsequent progression to endometrial carcinoma...
  6. doi request reprint Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells
    Silke Kaulfuss
    Institute of Human Genetics, University of Gottingen, Heinrich Düker Weg 12, Gottingen, Germany
    Mol Endocrinol 22:1606-21. 2008
    ..Leupaxin could function as a putative target for therapeutic interventions of a subset of advanced PCa...
  7. ncbi request reprint Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer
    Yan Cui
    Office of Health Assessment and Epidemiology, Los Angeles County Department of Public Health, Los Angeles, California, USA
    Cancer Epidemiol Biomarkers Prev 16:1682-5. 2007
    ..In conclusion, our data raise the possibility that relatively high levels of zinc, iron, and calcium in benign breast tissue may be associated with a modest increase in risk of subsequent breast cancer...
  8. ncbi request reprint Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?
    Derek Weycker
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 40:402-7. 2006
    ..In clinical practice, however, many patients receive shorter courses of therapy, even though the effectiveness of this regimen is unknown...
  9. ncbi request reprint Response to "Use of cervical cancer screening among insured women: the extent of missed opportunities" [Health Policy 73 (2005) 194-201]
    Ralph P Insinga
    Health Policy 77:245-6. 2006
  10. ncbi request reprint The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
    Michelle J Khan
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 7074, Rockville, MD 20852, USA
    J Natl Cancer Inst 97:1072-9. 2005
    ....
  11. ncbi request reprint The health care costs of cervical human papillomavirus--related disease
    Ralph P Insinga
    Department of Population Health Sciences, University of Wisconsin Madison, USA
    Am J Obstet Gynecol 191:114-20. 2004
    ..The purpose of this study was to examine the health care costs of cervical human papillomavirus-related disease in a US health care setting...
  12. ncbi request reprint Diagnoses and outcomes in cervical cancer screening: a population-based study
    Ralph P Insinga
    Department of Population Health Sciences, University of Wisconsin Madison, USA
    Am J Obstet Gynecol 191:105-13. 2004
    ..This study was undertaken to examine routine cervical cancer screening diagnoses and outcomes on an age-specific basis in a US population...
  13. ncbi request reprint Pap screening in a U.S. health plan
    Ralph P Insinga
    Department of Population Health Sciences, University of Wisconsin Madison, Madison, WI, USA
    Cancer Epidemiol Biomarkers Prev 13:355-60. 2004
    ..Sporadic screening was also more prevalent than expected based on prior self-reported data. Further opportunities exist for improving screening adherence, even within traditionally less vulnerable populations...
  14. ncbi request reprint Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis
    Mark E Sherman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 95:46-52. 2003
    ..We evaluated whether simultaneous screening with a Pap test and human papillomavirus (HPV) testing is useful for assessing the risk for cervical intraepithelial neoplasia (CIN) 3 or cervical cancer...
  15. ncbi request reprint Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women
    Philip E Castle
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA
    Cancer 95:2145-51. 2002
    ..The absolute risk of a subsequent abnormal Pap test for these women is uncertain. Therefore, the proper counseling and clinical management of these women is also uncertain...
  16. ncbi request reprint A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women
    Philip E Castle
    National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD 20892, USA
    J Natl Cancer Inst 94:1406-14. 2002
    ..However, these potential risk factors have not been adequately studied in prospective studies...